Linda Comp, Telerx09.05.13
The healthcare landscape has changed dramatically in recent years as a result of decreased profit margins, growing scrutiny from the public, increased pressure from regulatory agencies and the shifting political landscape. There is little doubt many more changes are yet to come. Pharma companies are increasingly turning to mergers and acquisitions, partnerships and outsourcing to consolidate their efforts and refocus on their core business.
Why the Change Now?
With the recent implementation of the Affordable Care Act (ACA), more pharma companies are adopting an outsourcing business model in their efforts to increase efficiency and concentrate on those services at the heart of their business, thereby managing costs for the patient and the company as a whole. A recent survey by Contract Pharma on outsourcing trends found that an increase in outsourcing spending was expected in the next year. Additionally, as the industry works to implement further changes related to the ACA, the reliance upon outsourcing expertise and partnership will be even more important for companies to remain profitable.
As if the ACA was
Why the Change Now?
With the recent implementation of the Affordable Care Act (ACA), more pharma companies are adopting an outsourcing business model in their efforts to increase efficiency and concentrate on those services at the heart of their business, thereby managing costs for the patient and the company as a whole. A recent survey by Contract Pharma on outsourcing trends found that an increase in outsourcing spending was expected in the next year. Additionally, as the industry works to implement further changes related to the ACA, the reliance upon outsourcing expertise and partnership will be even more important for companies to remain profitable.
As if the ACA was
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
